FLT1 and Hepatic fibrosis: Hepatic mRNA levels of Vegfa, Vegfr1 and Vegfr2 were increased in accordance with CCl4‐induced liver fibrosis and were significantly reduced in response to treatment with lenvatinib (Figure 5D).